Budget Impact Analysis of Tocilizumab, Infliximab and Etanercept Drugs for The Treatment of Rheumatoid Arthritis in Ecuador
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2970
https://www.valueinhealthjournal.com/article/S1098-3015(17)33304-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2716
First Page :
A937
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33304-1&doi=10.1016/j.jval.2017.08.2970